Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1988 3
1989 2
1990 1
1992 1
1995 1
1997 3
1998 2
2000 2
2001 2
2002 4
2003 2
2004 1
2005 1
2006 5
2007 3
2008 3
2009 3
2010 3
2011 2
2012 1
2013 7
2014 4
2015 3
2016 6
2017 5
2018 5
2019 1
2020 4
2021 11
2022 19
2023 12
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

113 results

Results by year

Filters applied: . Clear all
Page 1
Immune surveillance for vaccine-preventable diseases.
den Hartog G, van Binnendijk R, Buisman AM, Berbers GAM, van der Klis FRM. den Hartog G, et al. Expert Rev Vaccines. 2020 Apr;19(4):327-339. doi: 10.1080/14760584.2020.1745071. Epub 2020 Mar 29. Expert Rev Vaccines. 2020. PMID: 32223469 Review.
New iron chelators in anthracycline-induced cardiotoxicity.
Kaiserová H, Simunek T, Sterba M, den Hartog GJ, Schröterová L, Popelová O, Gersl V, Kvasnicková E, Bast A. Kaiserová H, et al. Among authors: den hartog gj. Cardiovasc Toxicol. 2007;7(2):145-50. doi: 10.1007/s12012-007-0020-6. Cardiovasc Toxicol. 2007. PMID: 17652820 Review.
Oxidative stress and antioxidants in interstitial lung disease.
Bast A, Weseler AR, Haenen GR, den Hartog GJ. Bast A, et al. Among authors: den hartog gj. Curr Opin Pulm Med. 2010 Sep;16(5):516-20. doi: 10.1097/MCP.0b013e32833c645d. Curr Opin Pulm Med. 2010. PMID: 20592594 Review.
Alternative strategies to increase the immunogenicity of COVID-19 vaccines in kidney transplant recipients not responding to two or three doses of an mRNA vaccine (RECOVAC): a randomised clinical trial.
Kho MML, Messchendorp AL, Frölke SC, Imhof C, Koomen VJ, Malahe SRK, Vart P, Geers D, de Vries RD, GeurtsvanKessel CH, Baan CC, van der Molen RG, Diavatopoulos DA, Remmerswaal EBM, van Baarle D, van Binnendijk R, den Hartog G, de Vries APJ, Gansevoort RT, Bemelman FJ, Reinders MEJ, Sanders JF, Hilbrands LB; RECOVAC collaborators. Kho MML, et al. Among authors: den hartog g. Lancet Infect Dis. 2023 Mar;23(3):307-319. doi: 10.1016/S1473-3099(22)00650-8. Epub 2022 Oct 27. Lancet Infect Dis. 2023. PMID: 36354032 Free PMC article. Clinical Trial.
Decline of RSV-specific antibodies during the COVID-19 pandemic.
den Hartog G, van Kasteren PB, Schepp RM, Teirlinck AC, van der Klis FRM, van Binnendijk RS. den Hartog G, et al. Lancet Infect Dis. 2023 Jan;23(1):23-25. doi: 10.1016/S1473-3099(22)00763-0. Epub 2022 Dec 1. Lancet Infect Dis. 2023. PMID: 36463892 Free PMC article. No abstract available.
Fourth mRNA COVID-19 vaccination in immunocompromised patients with haematological malignancies (COBRA KAI): a cohort study.
Hofsink Q, Haggenburg S, Lissenberg-Witte BI, Broers AEC, van Doesum JA, van Binnendijk RS, den Hartog G, Bhoekhan MS, Haverkate NJE, van Meerloo J, Burger JA, Bouhuijs JH, Smits GP, Wouters D, van Leeuwen EMM, Bontkes HJ, Kootstra NA, Vogels-Nooijen S, Rots N, van Beek J, Heemskerk MHM, Groen K, van Meerten T, Mutsaers PGNJ, van Gils MJ, Goorhuis A, Rutten CE, Hazenberg MD, Nijhof IS; COBRA KAI study team. Hofsink Q, et al. Among authors: den hartog g. EClinicalMedicine. 2023 Jul;61:102040. doi: 10.1016/j.eclinm.2023.102040. Epub 2023 Jun 15. EClinicalMedicine. 2023. PMID: 37337616 Free PMC article.
Asthma-Associated Long TSLP Inhibits the Production of IgA.
van Heerden D, van Binnendijk RS, Tromp SAM, Savelkoul HFJ, van Neerven RJJ, den Hartog G. van Heerden D, et al. Among authors: den hartog g. Int J Mol Sci. 2021 Mar 30;22(7):3592. doi: 10.3390/ijms22073592. Int J Mol Sci. 2021. PMID: 33808333 Free PMC article.
Antibody and T-Cell Responses 6 Months After Coronavirus Disease 2019 Messenger RNA-1273 Vaccination in Patients With Chronic Kidney Disease, on Dialysis, or Living With a Kidney Transplant.
Sanders JF, Messchendorp AL, de Vries RD, Baan CC, van Baarle D, van Binnendijk R, Diavatopoulos DA, Geers D, Schmitz KS, GeurtsvanKessel CH, den Hartog G, Kho MML, Koopmans MPG, van der Molen RG, Remmerswaal EBM, Rots N, Gansevoort RT, Bemelman FJ, Hilbrands LB, Reinders MEJ; VACcination Immune Response Study (RECOVAC) Collaborators. Sanders JF, et al. Among authors: den hartog g. Clin Infect Dis. 2023 Feb 8;76(3):e188-e199. doi: 10.1093/cid/ciac557. Clin Infect Dis. 2023. PMID: 35796536 Free PMC article. Clinical Trial.
Quantitative analysis of mRNA-1273 COVID-19 vaccination response in immunocompromised adult hematology patients.
Haggenburg S, Lissenberg-Witte BI, van Binnendijk RS, den Hartog G, Bhoekhan MS, Haverkate NJE, de Rooij DM, van Meerloo J, Cloos J, Kootstra NA, Wouters D, Weijers SS, van Leeuwen EMM, Bontkes HJ, Tonouh-Aajoud S, Heemskerk MHM, Sanders RW, Roelandse-Koop E, Hofsink Q, Groen K, Çetinel L, Schellekens L, den Hartog YM, Toussaint B, Kant IMJ, Graas T, de Pater E, Dik WA, Engel MD, Pierie CRN, Janssen SR, van Dijkman E, Poniman M, Burger JA, Bouhuijs JH, Smits G, Rots NY, Zweegman S, Kater AP, van Meerten T, Mutsaers PGNJ, van Doesum JA, Broers AEC, van Gils MJ, Goorhuis A, Rutten CE, Hazenberg MD, Nijhof IS. Haggenburg S, et al. Among authors: den hartog g. Blood Adv. 2022 Mar 8;6(5):1537-1546. doi: 10.1182/bloodadvances.2021006917. Blood Adv. 2022. PMID: 35114690 Free PMC article. Clinical Trial.
113 results